155 related articles for article (PubMed ID: 11870629)
1. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance.
Sonoda KH; Stein-Streilein J
Eur J Immunol; 2002 Mar; 32(3):848-57. PubMed ID: 11870629
[TBL] [Abstract][Full Text] [Related]
2. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance.
Faunce DE; Stein-Streilein J
J Immunol; 2002 Jul; 169(1):31-8. PubMed ID: 12077225
[TBL] [Abstract][Full Text] [Related]
3. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.
Sonoda KH; Exley M; Snapper S; Balk SP; Stein-Streilein J
J Exp Med; 1999 Nov; 190(9):1215-26. PubMed ID: 10544194
[TBL] [Abstract][Full Text] [Related]
4. Immune privilege: keeping an eye on natural killer T cells.
Hong S; Van Kaer L
J Exp Med; 1999 Nov; 190(9):1197-200. PubMed ID: 10544192
[No Abstract] [Full Text] [Related]
5. NKT cell-derived urokinase-type plasminogen activator promotes peripheral tolerance associated with eye.
Sonoda KH; Nakamura T; Young HA; Hart D; Carmeliet P; Stein-Streilein J
J Immunol; 2007 Aug; 179(4):2215-22. PubMed ID: 17675481
[TBL] [Abstract][Full Text] [Related]
6. Ocular immune privilege and CD1d-reactive natural killer T cells.
Sonoda KH; Stein-Streilein J
Cornea; 2002 Mar; 21(2 Suppl 1):S33-8. PubMed ID: 11995808
[TBL] [Abstract][Full Text] [Related]
7. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells.
Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE
J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503
[TBL] [Abstract][Full Text] [Related]
8. A role for CD1d-restricted NKT cells in injury-associated T cell suppression.
Faunce DE; Gamelli RL; Choudhry MA; Kovacs EJ
J Leukoc Biol; 2003 Jun; 73(6):747-55. PubMed ID: 12773507
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival of corneal allografts is dependent on intact CD1d-reactive NKT cells.
Sonoda KH; Taniguchi M; Stein-Streilein J
J Immunol; 2002 Feb; 168(4):2028-34. PubMed ID: 11823540
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific expansion of NKT and CD5+B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice.
Morshed SR; Mannoor K; Halder RC; Kawamura H; Bannai M; Sekikawa H; Watanabe H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2551-61. PubMed ID: 12207339
[TBL] [Abstract][Full Text] [Related]
11. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
Park JE; Wu DY; Prendes M; Lu SX; Ragupathi G; Schrantz N; Chapman PB
Immunology; 2008 Jan; 123(1):145-55. PubMed ID: 18154620
[TBL] [Abstract][Full Text] [Related]
12. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.
Lang GA; Devera TS; Lang ML
Blood; 2008 Feb; 111(4):2158-62. PubMed ID: 18077787
[TBL] [Abstract][Full Text] [Related]
13. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation.
Sonoda KH; Sakamoto T; Qiao H; Hisatomi T; Oshima T; Tsutsumi-Miyahara C; Exley M; Balk SP; Taniguchi M; Ishibashi T
Immunology; 2005 Nov; 116(3):390-9. PubMed ID: 16236129
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of tolerance induced by transforming growth factor-beta-treated antigen-presenting cells: CD8 regulatory T cells inhibit the effector phase of the immune response in primed mice through a mechanism involving Fas ligand.
Kosiewicz MM; Alard P; Liang S; Clark SL
Int Immunol; 2004 May; 16(5):697-706. PubMed ID: 15096489
[TBL] [Abstract][Full Text] [Related]
15. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
D'Orazio TJ; Mayhew E; Niederkorn JY
J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
[TBL] [Abstract][Full Text] [Related]
16. A role for natural killer T cells and CD1d molecules in counteracting suppression of hematopoiesis in mice induced by infection with murine cytomegalovirus.
Broxmeyer HE; Dent A; Cooper S; Hangoc G; Wang ZY; Du W; Gervay-Haque J; Sriram V; Renukaradhya GJ; Brutkiewicz RR
Exp Hematol; 2007 Apr; 35(4 Suppl 1):87-93. PubMed ID: 17379092
[TBL] [Abstract][Full Text] [Related]
17. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.
Sköld M; Xiong X; Illarionov PA; Besra GS; Behar SM
J Immunol; 2005 Sep; 175(6):3584-93. PubMed ID: 16148102
[TBL] [Abstract][Full Text] [Related]
18. CD1d-restricted natural killer T cells can down-regulate tumor immunosurveillance independent of interleukin-4 receptor-signal transducer and activator of transcription 6 or transforming growth factor-beta.
Terabe M; Khanna C; Bose S; Melchionda F; Mendoza A; Mackall CL; Helman LJ; Berzofsky JA
Cancer Res; 2006 Apr; 66(7):3869-75. PubMed ID: 16585215
[TBL] [Abstract][Full Text] [Related]
19. Role of NKT cells in allogeneic islet graft survival.
Yang SH; Jin JZ; Lee SH; Park H; Kim CH; Lee DS; Kim S; Chung NH; Kim YS
Clin Immunol; 2007 Sep; 124(3):258-66. PubMed ID: 17662658
[TBL] [Abstract][Full Text] [Related]
20. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection.
Baron JL; Gardiner L; Nishimura S; Shinkai K; Locksley R; Ganem D
Immunity; 2002 Apr; 16(4):583-94. PubMed ID: 11970881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
